Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label Safety Extension Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand

NCT02293564 is registered in ClinicalTrials.gov with XOMA (US) LLC as lead sponsor.

NCT NCT02293564
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02293564 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label Safety Extension Study of Gevokizumab in Active Inflammatory, Erosive Osteoarthritis of the Hand
Lead sponsor
XOMA (US) LLC
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2013
Completion date
Not reported
Enrollment
312 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis